Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02487160 · ClinicalTrials.gov registry record · Phase 3
Clinical Evaluation of the Lenstec SBL-3 Multifocal Intraocular Lens
A Phase 3 study, sponsored by Lenstec Incorporated.
- Completed
- Registry status
- Phase 3
- Development phase
- 499
- Enrollment target
NCT02487160: Completed Phase 3 study, sponsored by Lenstec Incorporated.
NCT02487160 is a Phase 3 study that has completed, run by Lenstec Incorporated. The registered enrollment target is 499 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (35% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02487160, a Phase 3 study, has completed, sponsored by Lenstec Incorporated.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 499 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the safety and performance of the SBL-3 intraocular lens.
Primary Outcome
a measure of near vision
Interventions
- DEVICE SBL-3 multifocal intraocular lens
- DEVICE Control monofocal intraocular lens
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 499 participants |
| Start Date | 2015-08 |
| Est. Completion | 2019-08 |
| Phase | Phase 3 |
What the finished NCT02487160 record still lists
NCT02487160 is an interventional study that assigns participants to a tested intervention. The registered 499 participants enrollment target is mid-sized for trials with a published cap, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (35% lower).
The record links to 0 conditions, and to 2 interventions - of which SBL-3 multifocal intraocular lens is the first listed.
NCT02487160 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02487160 about?
NCT02487160 is a clinical study titled "Clinical Evaluation of the Lenstec SBL-3 Multifocal Intraocular Lens". The purpose of this study is to evaluate the safety and performance of the SBL-3 intraocular lens.
What is the current status of trial NCT02487160?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 499 participants. The study started on 2015-08. Estimated completion is 2019-08.
What interventions are being tested in trial NCT02487160?
The interventions under investigation include: SBL-3 multifocal intraocular lens (DEVICE), Control monofocal intraocular lens (DEVICE).
Who is sponsoring clinical trial NCT02487160?
This trial is sponsored by Lenstec Incorporated, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02487160's enrollment target sits among peer trials
499 775th of 2000 higher than 1,226 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04137900 · 499 participants · Phase 1
Safety, Tolerability and Pharmacokinetics of a Monoclonal Antibody Specific to B-and T-Lymphocyte Attenuator (BTLA) as Monotherapy and in Combination With an Anti-PD1 Monoclonal Antibody for Injection in Subjects With Advanced Malignancies
- NCT06733480 · 499 participants · NA
Innovating Physical Therapy: A Pilot Study on Band Connect's Impact on Compliance, Satisfaction, and Revenue
- NCT00001230 · 500 participants
Host Response to Infection and Treatment in Filarial Diseases
- NCT00001529 · 500 participants
Improved Methods of Cell Selection for Bone Marrow Transplant Alternatives
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia